Progress Software just delivered a Q2 earnings beat that sent the stock up 16% on the week — yet the post-print picture is messier than the rally implies.
The most telling story is in how the Street responded. Analyst reactions on July 1 were constructive in rating but cautious on valuation. Oppenheimer kept its Outperform but cut its target from $57 to $50. DA Davidson held at Buy with a $40 target — below where several peers have been anchoring. Guggenheim reiterated Buy at $83, a figure that looks like an outlier against the cluster of targets in the $40-$50 range; that $83 target is likely stale or reflects different assumptions and should be treated with caution. The mean target across the active coverage sits near $50, implying roughly 48% upside from the $33.58 close — a wide gap that reflects how far the stock has fallen from where analysts were pricing it earlier this year, when targets ranged from $60 to $70. The March round of cuts was severe. Bulls see a disciplined infrastructure software vendor with steady recurring revenue and credible AI optionality. Bears point to ARR growing at just 2%, a cloud-native competitive threat, and management that is prioritizing debt paydown over reinvestment.
Short positioning has ticked modestly higher after the print, but the borrow market does nothing to amplify bear pressure. Short interest edged up about 1.9% over the week to nearly 10% of free float — a level worth watching on a mid-cap software name, but one that has actually been trending lower over the past month, down roughly 3.5% from late May. Cost to borrow is barely above 0.5%, unchanged in character from recent weeks. Availability remains generous at 451% of outstanding short interest, meaning lenders have far more shares available than bears are currently borrowing. That combination — meaningful but declining short interest, loose borrow conditions — looks more like residual skepticism than active conviction.
Options positioning has shifted sharply since the pre-earnings note. The put/call ratio has dropped to 0.80, sitting 1.7 standard deviations below its 20-day average of 0.97. That is the most call-heavy the options market has been relative to its own recent baseline, a clear reversal from the persistently defensive PCR readings above 1.0 that defined May and most of June. The shift began before the print and has held through it, suggesting call buyers were positioned for the beat and have not yet unwound those positions. The divergence between options bullishness and residual short interest is the live tension in the stock right now.
The earnings history adds one useful data point. The most recent comparable print — the Q1 release in late June — produced an 8% one-day gain and a 21% five-day move. This week's 16% weekly gain has already tracked that pattern. What the data does not show is whether the five-day follow-through holds when short sellers are sitting at 10% of float rather than covering into the rally.
The next scheduled event is the Q3 print on September 22. Between now and then, the question is whether analysts use the intervening months to revisit targets that still cluster well below prior-year levels — and whether short sellers, who have shown no urgency to cover despite a loose borrow market, begin to reduce a position that the options market is no longer endorsing.
See the live data behind this article on ORTEX.
Open PRGS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
